ICH adopts M12 guideline on drug interaction studies, releases draft M14 guidance on RWD
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesClinical TrialsGlobalICHPharmaceuticalsPharmacovigilanceQuality Assurance and ControlRegulatory Intelligence/PolicyRWE/RWD